5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.92▼ | 1.92▼ | 1.92▼ | 1.90▼ | 1.92▼ |
MA10 | 1.88▲ | 1.87▲ | 1.87▲ | 1.91▼ | 1.83▲ |
MA20 | 1.88▲ | 1.90▼ | 1.92▼ | 1.92▼ | 1.77▲ |
MA50 | 1.93▼ | 1.91▼ | 1.92▼ | 1.77▲ | 2.11▼ |
MA100 | 1.92▼ | 1.84▲ | 1.78▲ | 1.78▲ | 2.19▼ |
MA200 | 1.79▲ | 1.79▲ | 1.82▲ | 2.02▼ | 3.05▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | 0.005▲ | 0.000▼ | -0.017▼ | 0.054▲ |
RSI | 48.879▼ | 48.776▼ | 48.602▼ | 47.994▼ | 48.715▼ |
STOCH | 92.982▲ | 77.193 | 48.599 | 33.543 | 74.268 |
WILL %R | -26.316 | -58.209 | -58.209 | -69.444 | -34.783 |
CCI | 28.476 | 15.182 | -13.342 | -162.526▼ | 64.593 |
Tuesday, July 01, 2025 11:15 AM
Sino-American antibody company Adagene (Nasdaq: ADAG) has announced a strategic investment and option exercise by Sanofi (Euronext: SAN). Following on from a previous partnership between the two ...
|
Tuesday, July 01, 2025 05:43 AM
Adagene Inc. (NASDAQ:ADAG) saw its shares rise by 6.1% on Tuesday after the biotech firm revealed a strategic investment deal with French pharmaceutical giant Sanofi (EPA:SASY) worth up to $25 million ...
|
Tuesday, July 01, 2025 04:13 AM
Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 1.99 | 1.99 | 1.79 | 1.85 | 16,381 |
02/07/25 | 1.86 | 1.95 | 1.7467 | 1.94 | 50,348 |
01/07/25 | 2.03 | 2.10 | 1.74 | 1.85 | 685,229 |
30/06/25 | 1.93 | 2.00 | 1.93 | 1.95 | 7,455 |
27/06/25 | 1.92 | 1.92 | 1.92 | 1.92 | 955 |
26/06/25 | 1.935 | 1.98 | 1.90 | 1.90 | 27,014 |
25/06/25 | 1.90 | 1.95 | 1.90 | 1.94 | 1,908 |
24/06/25 | 1.96 | 1.96 | 1.92 | 1.9499 | 3,185 |
23/06/25 | 1.90 | 1.94 | 1.90 | 1.905 | 6,981 |
20/06/25 | 2.00 | 2.00 | 1.90 | 1.90 | 3,286 |
|
|
||||
|
|
||||
|
|